Physician
Premier Internal Medicine of Giles County, PLLC
Premier Internal Medicine of Giles County, PLLC was paid $2.36M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoPREMIER INTERNAL MEDICINE OF GILES COUNTY, PLLC
PULASKI, TN 38478
PULASKI, TN 38478
33aNPI1962662270assigned 06/10/2008
33bProvider typeInternal Medicine Physician
28Total paid$2.36M
24GClaims361,634
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#14 of 581
Median peer was paid$15K
This provider vs. median156×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,953 | $331K | |
| 2019 | 60,415 | $458K | |
| 2020 | 55,339 | $371K | |
| 2021 | 40,497 | $278K | |
| 2022 | 49,234 | $281K | |
| 2023 | 61,978 | $336K | |
| 2024incomplete | 54,218 | $302K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 39,681 | 29,242 | $1.35M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 23,807 | 16,978 | $623K |
| 95923 | 1.8% | 1,016 | 731 | $41K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 4,649 | 3,307 | $38K |
| 80305 | 1.6% | 11,324 | 8,412 | $37K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 888 | 677 | $37K |
| 93922 | <1% | 869 | 631 | $21K | |
| 94729 | <1% | 898 | 741 | $20K | |
| 99406 | <1% | 3,009 | 2,160 | $20K | |
| 95921 | <1% | 650 | 480 | $18K | |
| 94727 | <1% | 901 | 744 | $16K | |
| 99441 | <1% | 5,000 | 3,474 | $13K |
85 more codes
| 94010 | <1% | 544 | $8K | |
| 1160F | <1% | 38,523 | $8K | |
| 3078F | <1% | 19,081 | $7K | |
| 3074F | <1% | 23,367 | $7K | |
| 3079F | <1% | 11,567 | $6K | |
| 20553 | <1% | 322 | $6K | |
| 1159F | <1% | 26,840 | $6K | |
| 1126F | <1% | 19,530 | $6K | |
| 3008F | <1% | 31,690 | $6K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,713 | $6K |
| 94375 | <1% | 308 | $5K | |
| 1125F | <1% | 12,972 | $4K | |
| 99490 | Ccm add 20min | <1% | 1,814 | $4K |
| 95957 | <1% | 64 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,527 | $3K |
| 3077F | <1% | 3,209 | $3K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 92 | $3K |
| 95816 | <1% | 64 | $3K | |
| 3075F | <1% | 5,688 | $2K | |
| 93000 | <1% | 270 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 103 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 32 | $2K |
| 3080F | <1% | 1,546 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 275 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 17 | $2K |
| 95250 | <1% | 73 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 26 | $1K |
| 90686 | <1% | 174 | $1K | |
| 90674 | <1% | 121 | $1K | |
| 20610 | <1% | 58 | $1K | |
| 93925 | <1% | 16 | $893.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,890 | $743.02 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 25 | $728.46 |
| 20552 | <1% | 30 | $659.46 | |
| 90688 | <1% | 96 | $596.41 | |
| 93880 | <1% | 12 | $568.55 | |
| 95251 | <1% | 58 | $563.69 | |
| 81002 | <1% | 586 | $515.58 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 172 | $490.10 |
| 96127 | <1% | 213 | $470.22 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 30 | $393.36 |
| 92546 | <1% | 15 | $389.52 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $375.28 |
| 36415 | Collection of venous blood by venipuncture | <1% | 525 | $338.16 |
| 96138 | <1% | 64 | $331.10 | |
| 96139 | <1% | 28 | $307.54 | |
| 96125 | <1% | 71 | $219.39 | |
| 95943 | <1% | 51 | $218.01 | |
| 93040 | <1% | 64 | $183.70 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 66 | $134.06 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $111.24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 80 | $100.20 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 696 | $69.31 |
| 90756 | <1% | 47 | $51.21 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 84 | $49.07 |
| 92547 | <1% | 15 | $47.07 | |
| G0008 | Administration of influenza virus vaccine | <1% | 119 | $30.84 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 37 | $12.15 |
| J3490 | Unclassified drugs | <1% | 145 | $4.99 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 725 | $4.99 |
| J7509 | Methylprednisolone oral, per 4 mg | <1% | 45 | $4.80 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,904 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 14,052 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 7,194 | $0.00 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 2,542 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 9,102 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 3,432 | $0.00 |
| G8477 | Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg | 0% | 169 | $0.00 |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 274 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 53 | $0.00 |
| 99499 | 0% | 173 | $0.00 | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 0% | 71 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 89 | $0.00 |
| 1158F | 0% | 155 | $0.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 147 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 7,304 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 9,849 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 1,275 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 1,208 | $0.00 |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 1,015 | $0.00 |
| G8473 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed | 0% | 30 | $0.00 |
| 3044F | 0% | 58 | $0.00 | |
| 4010F | 0% | 30 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 71 | $0.00 |
| 1170F | 0% | 98 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALUYI, CLEMENT (PRESIDENT/CEO)